In the pipeline.
What's next for Hemispherian.

Presently, we are advancing our lead compound, GLIX1, in preclinical studies for the treatment of glioblastoma multiforme. Also, in the pipeline, at the proof of concept stage, is GLIX5, which is indicated in a much broader range of cancers. In addition, we have two compounds in late discovery stage. Further compounds are in the early stages of discovery.

Diagram of Hemispherian's pipeline Diagram of Hemispherian's pipeline